Preoperative screening and prehabilitation strategies prior to ileocolic resection in patients with Crohn’s disease are not incorporated in routine care.

Bak MTJ, van Ruler O, Stassen L, Ruiterkamp M, Arkenbosch JHC, Dijkstra G, Campmans-Kuijpers MJE, van Meeteren NLU, Bongers BC, Romberg-Camps M, van der Marel S, Hoentjen F, van Dongen KW, West R, van der Woude J, de Vries AC; Dutch Initiative Crohn and Colitis (ICC)...

Therapeutic drug monitoring of methotrexate in patients with Crohn’s disease

van de Meeberg MM, Fidder HH, Oldenburg B, Sundaresan J, Struys EA, Montazeri NSM, Mares WGN, Mahmmod N, van Asseldonk DP, Lutgens MWMD, Kuyvenhoven JP, Rietdijk ST, Nissen LHC, Koehestanie P, de Boer NKH, de Jonge R, Bouma G, Bulatović Ćalasan M; Dutch Initiative on...

Prognostic value of the modified Rutgeerts’ score for long-term outcomes after primary ileocecal resection in Crohn’s disease

Bak MTJ, Huinink STB, Erler NS, Bodelier AGL, Dijkstra G, Romberg-Camps MJ, de Boer NKH, Hoentjen F, Stassen LPS, van der Meulen-de Jong AE, West RL, van Ruler O, van der Woude CJ, de Vries AC; Dutch Initiative on Crohn and Colitis (ICC); Dutch Initiative on Crohn and...

Smoking and colorectal neoplasia in patients with inflammatory bowel disease: Dose-effect relationship

Wijnands AM, Elias SG, Dekker E, Fidder HH, Hoentjen F, Ten Hove JR, Maljaars PWJ, van der Meulen-de Jong AE, Mooiweer E, Ouwehand RJ, Penning de Vries BBL, Ponsioen CY, van Schaik FDM, Oldenburg B; Dutch Initiative on Crohn’s and Colitis (ICC). United European...

Cumulative exposure to immunomodulators increases risk of cervical neoplasia in women with inflammatory bowel disease

Kreijne JE, Goetgebuer RL, Erler NS, De Boer NK, Siebers AG, Dijkstra G, van Kemenade FA, Hoentjen F, Oldenburg B, van der Meulen AE, Ponsioen CIJ, Pierik MJ, van der Woude CJ, de Vries AC; Dutch Initiative on Crohn and Colitis (ICC). Aliment Pharmacol Ther. 2023...